Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 1467 entries
View as:

Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03637764 Org: User:
Start: 08/06/18 End: 05/11/22 Due: 05/11/23

Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01140581 Org: User:
Start: 09/30/10 End: 12/31/11 Due: 12/31/12

Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day

Phase: N/A Priority: Normal
NCT ID: NCT01234597 Org: User:
Start: 12/31/12 End: 04/30/15 Due: 04/30/16

VALID : VAlproate Versus LIthium in Bipolar Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00264173 Org: User:
Start: 02/29/04 End: 09/30/06 Due: 09/30/07

A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol

Phase: N/A Priority: Normal
NCT ID: NCT02940379 Org: User:
Start: 10/31/16 End: 12/31/16 Due: 12/31/17

Endometrial Cancer - LOHP Alone and With 5FU

Phase: N/A Priority: Normal
NCT ID: NCT00612495 Org: User:
Start: 01/31/01 End: 03/31/05 Due: 03/31/06

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01095302 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00087802 Org: User:
Start: 03/31/04 End: - Due: -

Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT00976027 Org: User:
Start: 09/30/09 End: 04/30/12 Due: 04/30/13

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00021255 Org: User:
Start: 04/30/01 End: 12/31/14 Due: 12/31/15

First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04521738 Org: User:
Start: 04/25/19 End: 09/26/19 Due: 09/26/20

Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04418661 Org: User:
Start: 06/09/20 End: 04/04/24 Due: 04/04/25

Oxaliplatin in Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00263354 Org: User:
Start: 10/31/03 End: 07/31/06 Due: 07/31/07

Venous Thromboembolism Taskforce Audit Program

Phase: N/A Priority: Normal
NCT ID: NCT00535171 Org: User:
Start: 06/30/07 End: - Due: -

Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01061723 Org: User:
Start: 02/28/10 End: 06/30/11 Due: 06/30/12

Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01444001 Org: User:
Start: 02/28/07 End: 08/31/07 Due: 08/31/08

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Phase: N/A Priority: Normal
NCT ID: NCT05231668 Org: User:
Start: 08/25/22 End: 11/12/24 Due: 11/12/25

Rasburicase for Hyperuricemia

Phase: N/A Priority: Normal
NCT ID: NCT00290992 Org: User:
Start: 06/30/05 End: 04/30/06 Due: 04/30/07

Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01940965 Org: User:
Start: 09/30/13 End: 07/31/15 Due: 07/31/16

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT00230217 Org: User:
Start: 03/31/04 End: 07/31/06 Due: 07/31/07

TELI COM - Telithromycin in Children With Otitis Media

Phase: N/A Priority: Normal
NCT ID: NCT00315003 Org: User:
Start: 01/31/06 End: 07/31/06 Due: 07/31/07

A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01436565 Org: User:
Start: 11/30/11 End: 05/31/14 Due: 05/31/15

Canadian Outpatient VTE Management Registry

Phase: N/A Priority: Normal
NCT ID: NCT01133002 Org: User:
Start: 08/31/07 End: 06/30/10 Due: 06/30/11

European Study of Dronedarone in Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00697086 Org: User:
Start: 08/31/02 End: 06/30/04 Due: 06/30/05

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04270409 Org: User:
Start: 06/16/20 End: 10/21/33 Due: 10/21/34